Niclosamide inhibits ovarian carcinoma growth by interrupting cellular bioenergetics

Background: Ovarian carcinoma is a common malignant tumor of the female reproductive organs with an incidence rate second only to cervical and endometrial cancers. In the past 10 years, anticancer therapy has focused on Niclosamide, an anthelmintic teniacide that is commonly used against tapeworms a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shangguan, Fugen, Liu, Yan, Ma, Li, Qu, Guiwu, Lv, Qing, An, Jing, Yang, Shude, Lu, Bin, Cao, Qizhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150452/
https://www.ncbi.nlm.nih.gov/pubmed/32284741
http://dx.doi.org/10.7150/jca.41418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150452/
https://www.ncbi.nlm.nih.gov/pubmed/32284741
http://dx.doi.org/10.7150/jca.41418

Ejemplares similares